Common Stock, Shares, Outstanding of IMMUCELL CORP /DE/ from 31 Dec 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
IMMUCELL CORP /DE/ quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2015 to 30 Sep 2025.
  • IMMUCELL CORP /DE/ Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 9,045,851, a 2.4% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

IMMUCELL CORP /DE/ Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 9,045,851 +212,754 +2.4% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 9,045,851 +1,212,771 +15% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 8,982,623 +1,231,759 +16% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 8,979,091 +1,228,227 +16% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 8,833,097 +1,086,233 +14% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 7,833,080 +86,216 +1.1% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 7,750,864 +4,000 +0.05% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 7,750,864 +4,000 +0.05% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 7,746,864 0 0% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 7,746,864 0 0% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 7,746,864 +4,000 +0.05% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 7,746,864 +5,000 +0.06% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 7,746,864 +5,000 +0.06% 30 Sep 2022 10-Q 21 Nov 2022 2022 Q3
Q2 2022 7,746,864 +5,000 +0.06% 30 Jun 2022 10-Q/A 21 Nov 2022 2022 Q2
Q1 2022 7,742,864 +522,028 +7.2% 31 Mar 2022 10-Q/A 21 Nov 2022 2022 Q1
Q4 2021 7,741,864 +523,028 +7.2% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 7,741,864 +528,945 +7.3% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 7,741,864 +528,945 +7.3% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 7,220,836 +7,917 +0.11% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 7,218,836 +5,917 +0.08% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 7,212,919 +3,324 +0.05% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 7,212,919 +3,324 +0.05% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 7,212,919 +3,324 +0.05% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 7,212,919 +1,643,957 +30% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 7,209,595 +1,724,867 +31% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 7,209,595 +1,725,867 +31% 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 7,209,595 +1,729,438 +32% 31 Mar 2019 10-Q 13 May 2019 2019 Q1
Q4 2018 5,568,962 +92,765 +1.7% 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q3 2018 5,484,728 +433,338 +8.6% 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 5,483,728 +635,338 +13% 30 Jun 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 5,480,157 +631,767 +13% 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 5,476,197 +628,807 +13% 31 Dec 2017 10-K 22 Mar 2019 2018 FY
Q3 2017 5,051,390 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 4,848,390 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 4,848,390 31 Mar 2017 10-Q 11 May 2017 2017 Q1
Q4 2016 4,847,390 +1,792,356 +59% 31 Dec 2016 10-K 29 Mar 2018 2017 FY
Q4 2015 3,055,034 31 Dec 2015 10-K 30 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.